We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+2.56%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$23B
AUM Growth
+$654M
Cap. Flow
+$6.71M
Cap. Flow %
0.03%
Top 10 Hldgs %
15.45%
Holding
1,532
New
151
Increased
540
Reduced
484
Closed
141

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$284M
2
DB icon
Deutsche Bank
DB
+$159M
3
NSC icon
Norfolk Southern
NSC
+$108M
4
HPQ icon
HP
HPQ
+$92.2M
5
DD
Du Pont De Nemours E I
DD
+$80.9M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$161M
2
F icon
Ford
F
+$87.9M
3
WHR icon
Whirlpool
WHR
+$74M
4
PNC icon
PNC Financial Services
PNC
+$72.9M
5
EMN icon
Eastman Chemical
EMN
+$72.9M

Sector Composition

Rank Sector Weight
1 Healthcare 15.62%
2 Technology 14.22%
3 Financials 13.17%
4 Industrials 11.49%
5 Energy 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNS
776
DELISTED
Janus Capital Group Inc
JNS
$1.73M 0.01%
158,700
-18,600
-10% -$210K
EWX icon
777
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$659M
$1.72M 0.01%
36,350
+1,780
+5% +$81K
FEZ icon
778
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.34B
$1.72M 0.01%
40,364
BHE icon
779
Benchmark Electronics
BHE
$2.61B
$1.7M 0.01%
+75,000
New +$1.75M
BGC
780
DELISTED
General Cable Corporation
BGC
$1.7M 0.01%
66,200
+36,800
+125% +$1.07M
ENZL icon
781
iShares MSCI New Zealand ETF
ENZL
$74.2M
$1.69M 0.01%
39,400
QLGC
782
DELISTED
QLOGIC CORP
QLGC
$1.69M 0.01%
132,200
+66,300
+101% +$775K
KIM icon
783
Kimco Realty
KIM
$15.4B
$1.68M 0.01%
76,900
+31,415
+69% +$669K
UPBD icon
784
Upbound Group
UPBD
$1.03B
$1.68M 0.01%
63,200
-207,100
-77% -$5.61M
EPZM
785
DELISTED
Epizyme, Inc
EPZM
$1.66M 0.01%
+73,000
New +$2.21M
APH icon
786
Amphenol
APH
$191B
$1.66M 0.01%
289,600
-271,200
-48% -$1.51M
SYA
787
DELISTED
SYMETRA FINANCIAL CORPORATION COMMON STOCK
SYA
$1.66M 0.01%
+83,668
New +$1.62M
COLM icon
788
Columbia Sportswear
COLM
$2.89B
$1.65M 0.01%
+39,820
New +$1.59M
CRUS icon
789
Cirrus Logic
CRUS
$6.12B
$1.64M 0.01%
82,500
+64,600
+361% +$1.23M
FLOT icon
790
iShares Floating Rate Bond ETF
FLOT
$10.8B
$1.64M 0.01%
32,310
+8,490
+36% +$430K
ACOR
791
DELISTED
Acorda Therapeutics
ACOR
$1.63M 0.01%
359
+19
+6% +$76.8K
ACN icon
792
Accenture
ACN
$118B
$1.62M 0.01%
20,310
+2,712
+15% +$223K
BF.B icon
793
Brown-Forman Class B
BF.B
$12B
$1.61M 0.01%
+56,250
New +$1.47M
ESV
794
DELISTED
Ensco Rowan plc
ESV
$1.61M 0.01%
7,615
+1,725
+29% +$361K
HOT
795
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$1.6M 0.01%
20,156
PKD
796
DELISTED
Parker Drilling Company
PKD
$1.59M 0.01%
15,000
-10,000
-40% -$1.14M
CMA
797
DELISTED
Comerica
CMA
$1.59M 0.01%
30,700
-1,211,000
-98% -$58.3M
HRL icon
798
Hormel Foods
HRL
$11.4B
$1.58M 0.01%
64,294
+12,600
+24% +$290K
OGE icon
799
OGE Energy
OGE
$9.44B
$1.58M 0.01%
42,870
+800
+2% +$28K
IDXX icon
800
Idexx Laboratories
IDXX
$40.2B
$1.57M 0.01%
25,884

Similar funds

Axa's Q1 2014 Portfolio in Review

As of Q1 2014, Axa held 1,532 positions worth $23B, up 2.9% from $22.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Axa's Q1 2014 filing shows 151 new, 540 increased, 484 reduced and 141 closed positions. Its largest new stake was Celanese: 949,936 shares worth $52.7M. The largest sale was Eli Lilly, an estimated $161M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q1 2014 buy was Celanese: 949,936 shares worth $52.7M.
  • Axa added most to Verizon in Q1 2014, an estimated $284M increase.
  • Axa's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $161M.
  • Axa fully exited Avon Products, Inc. in Q1 2014, selling an estimated $53.7M.
  • Axa's ten largest holdings make up 15% of its $23B portfolio in Q1 2014.
  • Axa opened 151 new positions and closed 141 in Q1 2014.
  • Axa's portfolio value rose 2.9% quarter-over-quarter to $23B.

Based on Axa's 13F filing for Q1 2014, filed 13 May 2014.